Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Manitoba

$33,000.00

Impact of chromogranin-A on gut smooth muscle contraction

FY 2024-25

Summary
The capacity to adapt to environmental stresses is critical for the viability of all life forms, and this is valid also at the cellular level. The molecular players and pathways by which cells respond to stress are often evolutionarily conserved in higher organisms. The long-term goal of my Discovery research program is to identify the mechanisms underlying the gut physiological effects of some evolutionarily highly-conserved stress proteins known as the chromogranin (CHG)-A and its derived peptides. Due to the strategic location of enterochromaffin (EC) cells at the interface of the gut mucosa, CHGA and its derived peptides, found in EC cells, should play an important role in relation to gut physiology. But their roles remain to be described. Primary gut function is the digestion and the propulsion of dietary nutrients via the microbiota and smooth muscle contractions (SMCs). Microbiota imbalance and its fermentation by-products represented by short-fatty-acids (SCFAs) have been proven to contribute to chyme dysfunction propulsion and to the decrease in endocrine factors released from EC cells. As my group's previous work has shown effects of some of the CHGA derived peptides on colonic smooth muscle contraction, somatovisceral pain, permeability and gut microbiota, my short-term goals are conducted under the guiding hypothesis that in physiological conditions CHGA is a crucial component in maintaining the gut microbiota, fermenting by-products, SCFAs, and SMCs. My study aims to determine physiological targets of the CHGA pathway, forming the groundwork to delineate further the uncharacterized signal transduction pathways mediating these effects. AIM 1. To determine the effect of the absence of CHGA on the microbiota. Hypothesis: CHGA influences gut microbiota composition at the level of the feces and the mucosa. AIM 2. To determine the extent to which the microbiota composition impacts colonic SMC. Hypothesis: The modification of the gut microbiota and SCFAs in the absence of CHGA influence SMC. AIM 3. To define if a fecal microbiota transfer (FMT) can rescue the disturbance of the SMC in the absence of CHGA. Hypothesis: Restoration of a conventional microbiota normalizes SMC in CHGA-/- mice Through the CHGA-deficient mouse colony established at my university, I will decipher how the lack of CHGA influences SMC and the enteric nervous system (organ bath technique) and the gut microbiota (metagenomic technique, proteomics). Pharmacological studies will delineate the pathways implicated. The work will provide opportunities to HQP to work in a multidisciplinary environment and foster their development to independent scientists. Over this cycle, PhD student (Diarra), who has initiated the studies, will be assigned to the Aim1. Ph.D. & MSc students recruited in summer 2023 will complete Aim 3. MSc student recruited in Summer 2022 will work on Aim 2. BSc summer students will help graduate students.
Program
Discovery Grants Program - Individual
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2022-03626
Name nom
Ghia, Jean-Eric
Department département
Immunology
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5504
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal physiology and metabolism
Research subject fr
Physiologie et métabolisme des animaux
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Impact of chromogranin-A on gut smooth muscle contraction
Keywords
gut physiology; smooth muscle contraction; enterochromaffine cells; chromogranin; microbiota
Application summary
The capacity to adapt to environmental stresses is critical for the viability of all life forms, and this is valid also at the cellular level. The molecular players and pathways by which cells respond to stress are often evolutionarily conserved in higher organisms. The long-term goal of my Discovery research program is to identify the mechanisms underlying the gut physiological effects of some evolutionarily highly-conserved stress proteins known as the chromogranin (CHG)-A and its derived peptides. Due to the strategic location of enterochromaffin (EC) cells at the interface of the gut mucosa, CHGA and its derived peptides, found in EC cells, should play an important role in relation to gut physiology. But their roles remain to be described. Primary gut function is the digestion and the propulsion of dietary nutrients via the microbiota and smooth muscle contractions (SMCs). Microbiota imbalance and its fermentation by-products represented by short-fatty-acids (SCFAs) have been proven to contribute to chyme dysfunction propulsion and to the decrease in endocrine factors released from EC cells. As my group's previous work has shown effects of some of the CHGA derived peptides on colonic smooth muscle contraction, somatovisceral pain, permeability and gut microbiota, my short-term goals are conducted under the guiding hypothesis that in physiological conditions CHGA is a crucial component in maintaining the gut microbiota, fermenting by-products, SCFAs, and SMCs. My study aims to determine physiological targets of the CHGA pathway, forming the groundwork to delineate further the uncharacterized signal transduction pathways mediating these effects. AIM 1. To determine the effect of the absence of CHGA on the microbiota. Hypothesis: CHGA influences gut microbiota composition at the level of the feces and the mucosa. AIM 2. To determine the extent to which the microbiota composition impacts colonic SMC. Hypothesis: The modification of the gut microbiota and SCFAs in the absence of CHGA influence SMC. AIM 3. To define if a fecal microbiota transfer (FMT) can rescue the disturbance of the SMC in the absence of CHGA. Hypothesis: Restoration of a conventional microbiota normalizes SMC in CHGA-/- mice Through the CHGA-deficient mouse colony established at my university, I will decipher how the lack of CHGA influences SMC and the enteric nervous system (organ bath technique) and the gut microbiota (metagenomic technique, proteomics). Pharmacological studies will delineate the pathways implicated. The work will provide opportunities to HQP to work in a multidisciplinary environment and foster their development to independent scientists. Over this cycle, PhD student (Diarra), who has initiated the studies, will be assigned to the Aim1. Ph.D. & MSc students recruited in summer 2023 will complete Aim 3. MSc student recruited in Summer 2022 will work on Aim 2. BSc summer students will help graduate students.
University of Manitoba - $33,000 Grant (2024-25) | Canada Spends